FDA De Novo For Aletta Creates New Regulatory Category For Robotic Phlebotomy

The FDA clearance of Aletta via De Novo creates a new regulatory pathway for robotic phlebotomy devices in the U.S., establishing a precedent and classification for this emerging category of medical robots.

This Wire brief sits within Fusion42's coverage of Medtech, and 3 sources have reported it between 19 Aug 2026 and 20 Aug 2026.